Kyriakos P. Papadopoulos

机构：South Texas Accelerated Research Therapeutics · ORCID：0000-0002-0667-2620

发表论文 763 篇 · 总被引 18421 次 · h-index 64

代表论文

SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial (2026 · Nature Medicine · 被引 3)
Phase 1 LITESPARK-001 study of belzutifan in participants with advanced solid tumors: Results of the glioblastoma expansion cohort (2025 · Neuro-Oncology Advances · 被引 3)
Targeting of Wnt–β-Catenin Pathway in Recurrent Ameloblastoma (2026 · New England Journal of Medicine · 被引 1)
Fianlimab, a human lymphocyte activation gene‐3 monoclonal antibody, in combination with cemiplimab: Tumor‐specific expansion cohorts in advanced malignancies (2026 · Cancer · 被引 1)
Author Correction: SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial (2026 · Nature Medicine)
Table S6 from A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation (2026)